CIBA Vision echoes Pfizer's call for surgical business buyers

Author(s):

Duluth, GA-Less than a month after Pfizer Inc. announced it would consider selling off the surgical business it acquired with its merger with Pharmacia Corp. (Ophthalmology Times, Sept. 1 issue, Page 3), another large manufacturer of ophthalmic surgical products has announced it is pondering selling the surgical segment of its business as well.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!

Related Videos

Part 6: Biggest innovations in ophthalmology in 50 years

Part 5: Biggest innovations in ophthalmology in 50 years

Part 4: Biggest innovations in ophthalmology in 50 years

NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula

Part 3: Biggest innovations in ophthalmology in 50 years

(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025

Setting the stage in LA: Neda Shamie, MD, on the 19th Annual Controversies in Modern Eye Care

Part 2: Biggest innovations in ophthalmology in 50 years

Part 1: Biggest innovations in ophthalmology in 50 years

World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD

$(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD$

The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD

CIBA Vision echoes Pfizer's call for surgical business buyers

Newsletter